Paulson & Co. Inc.
- SEC CIK
- 0001035674
- Latest filing
- Aug 14, 2026
The latest 13F from Paulson & Co. Inc. covers Q2 2026 (filed Aug 14, 2026): 8 long positions worth $2.58B. The top 10 holdings make up 100.0% of the portfolio, and the largest is Madrigal Pharmaceuticals, Inc. (MDGL) at 27.9%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 1
- Est. +$1.77M
- Added
- 1
- Est. +$9.78M
- Reduced
- 2
- Est. −$163.9M
- Sold out
- 2
- Est. −$159.5M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $2.58B
- −$535.9M (−17.2%) vs. prior quarter
- Positions
- 8
- −1 vs. prior quarter
- Top 10 concentration
- 100.0%
- Top 10 as share of value
- Turnover
- 0.4%
- Q2 2026, one quarter
- Average holding period
- 19.5 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $4.35B (Q1 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 8 | $2.58B | MDGLPPTAAAMI | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 9 | $3.11B | PPTAMDGLAAMI | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 9 | $3.26B | MDGLPPTABHC | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 10 | $2.97B | MDGLPPTABHC | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 15 | $2.01B | MDGLPPTAAAMI | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 14 | $1.75B | MDGLPPTAAAMI | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 13 | $1.65B | MDGLPPTAAAMI | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 15 | $1.43B | MDGLPPTAAAMI | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 16 | $1.35B | MDGLAAMIBHC | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 18 | $1.45B | MDGLBHCAAMI | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 17 | $1.11B | MDGLBHCAAMI | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 18 | $1.12B | HZNPBHCAAMI | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 21 | $1.02B | BHCAAMIPPTA | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 20 | $1.20B | BHCAAMING | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 22 | $1.11B | AAMIHZNPBHC | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 28 | $1.37B | HZNPBHCAAMI | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 32 | $2.03B | HZNPBHCAAMI | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 33 | $3.25B | HZNPBHCAAMI | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 36 | $3.24B | BHCHZNPAAMI | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 37 | $3.51B | BHCHZNPAAMI | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 39 | $4.18B | BHCHZNPAAMI | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 35 | $4.35B | BHCHZNPAAMI | – | SEC |
13D and 13G filings
Companies where Paulson & Co. Inc. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
7 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| THMInternational Tower Hill Mines Ltd | 13D/A | 39.90%104.5M shares | +1.80 ppfrom 38.10% | Jan 22, 20245 filings | Apr 20, 2026 | SEC |
| PPTAPerpetua Resources Corp. | 13D/A | 31.20%32.3M shares | – | Aug 27, 20212 filings | Jun 16, 2025 | SEC |
| THRYThryv Holdings, Inc. | 13G/A | 19.12%8.44M shares | +9.14 ppfrom 9.98% | Feb 16, 20215 filings | Mar 3, 2026 | SEC |
| BHCBausch Health Companies Inc. | 13D/A | 19.10%70.8M shares | +10.20 ppfrom 8.90% | May 21, 20253 filings | Aug 14, 2025 | SEC |
| AAMIAcadian Asset Management Inc. | 13D/A | 16.40%5.84M shares | −5.20 ppfrom 21.60% | Nov 5, 20215 filings | Jun 22, 2026 | SEC |
| NGNovagold Resources Inc | 13G/A | 9.80%40.0M shares | – | Feb 16, 20214 filings | Aug 14, 2025 | SEC |
| MDGLMadrigal Pharmaceuticals, Inc. | 13G/A | 6.10%1.39M shares | −1.40 ppfrom 7.50% | Nov 13, 20235 filings | May 15, 2026 | SEC |
Latest filings
31 filings on file made by Paulson & Co. Inc. or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| AAMIAcadian Asset Management Inc. | Jun 22, 20265:12 PM ET | 13D/A | 16.40%5.84M shares | −5.20 ppfrom 21.60% | Jun 17, 2026 | SEC |
| MDGLMadrigal Pharmaceuticals, Inc. | May 15, 20264:43 PM ET | 13G/A | 6.10%1.39M shares | −1.40 ppfrom 7.50% | Mar 31, 2026 | SEC |
| THMInternational Tower Hill Mines Ltd | Apr 20, 20268:08 PM ET | 13D/A | 39.90%104.5M shares | +1.80 ppfrom 38.10% | Apr 16, 2026 | SEC |
| THRYThryv Holdings, Inc. | Mar 3, 20269:07 PM ET | 13G/A | 19.12%8.44M shares | +9.14 ppfrom 9.98% | Feb 27, 2026 | SEC |
| MDGLMadrigal Pharmaceuticals, Inc. | Feb 17, 20265:19 PM ET | 13G/A | 7.50%1.71M shares | – | Dec 31, 2025 | SEC |
| THMInternational Tower Hill Mines Ltd | Jan 30, 20265:01 PM ET | 13D/A | 38.10%99.6M shares | +4.10 ppfrom 34.00% | Jan 28, 2026 | SEC |
| THMInternational Tower Hill Mines Ltd | Jan 27, 20266:20 PM ET | 13D/A | 34.00%88.3M shares | +0.20 ppfrom 33.80% | Jan 27, 2026 | SEC |
| AAMIAcadian Asset Management Inc. | Sep 5, 20254:48 PM ET | 13D/A | 21.60%7.74M shares | – | Sep 3, 2025 | SEC |
| BHCBausch Health Companies Inc. | Aug 14, 20259:38 PM ET | 13D/A | 19.10%70.8M shares | +10.20 ppfrom 8.90% | Aug 14, 2025 | SEC |
| NGNovagold Resources Inc | Aug 14, 20255:35 PM ET | 13G/A | 9.80%40.0M shares | – | Jun 30, 2025 | SEC |
| BHCBausch Health Companies Inc. | Jun 17, 20254:39 PM ET | 13D/A | 8.90%32.8M shares | +1.80 ppfrom 7.10% | Jun 13, 2025 | SEC |
| PPTAPerpetua Resources Corp. | Jun 16, 20257:22 PM ET | 13D/A | 31.20%32.3M shares | – | Jun 10, 2025 | SEC |
| BHCBausch Health Companies Inc. | May 21, 20257:39 PM ET | 13D/A | 7.10%26.4M shares | – | May 20, 2025 | SEC |
| THMInternational Tower Hill Mines Ltd | Mar 5, 20254:01 PM ET | 13D/A | 33.80%70.2M shares | – | Mar 3, 2025 | SEC |
| THRYThryv Holdings, Inc. | Feb 14, 20255:37 PM ET | 13G/A | 9.98%4.28M shares | – | Dec 31, 2024 | SEC |
| MDGLMadrigal Pharmaceuticals, Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| NGNovagold Resources Inc | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| MDGLMadrigal Pharmaceuticals, Inc. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| NGNovagold Resources Inc | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| THMInternational Tower Hill Mines Ltd | Jan 22, 2024 | 13D/AOld format | – | – | – | SEC |